Emerald Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,100
Closed -$35.4K 218
2022
Q4
$35.4K Hold
1,100
﹤0.01% 226
2022
Q3
$39K Hold
1,100
﹤0.01% 227
2022
Q2
$45K Hold
1,100
﹤0.01% 233
2022
Q1
$64K Hold
1,100
﹤0.01% 234
2021
Q4
$65K Buy
+1,100
New +$66.8K ﹤0.01% 252
2021
Q3
Sell
-1,100
Closed -$66K 245
2021
Q2
$66K Buy
+1,100
New +$55.1K ﹤0.01% 256
2021
Q1
Sell
-600
Closed -$23K 250
2020
Q4
$23K Sell
600
-500
-45% -$16.5K ﹤0.01% 276
2020
Q3
$36K Sell
1,100
-200
-15% -$8.47K ﹤0.01% 264
2020
Q2
$59K Buy
+1,300
New +$66.4K ﹤0.01% 245

Other funds holding ATEX

Emerald Advisers's ATEX Position: Q1 2023 in Review

Emerald Advisers sold out of Anterix (ATEX) in Q1 2023, closing a stake of 1,100 shares — an estimated $35.4K sold.

Emerald Advisers first reported a position in ATEX in Q2 2020 and held it in 9 quarters. The position peaked at $66K in Q2 2021. 88 funds tracked by Wall St. Rank hold ATEX as of Q1 2023.

  • Emerald Advisers reported no remaining Anterix position as of Q1 2023 after selling out during the quarter.
  • Emerald Advisers sold 1,100 Anterix shares in Q1 2023, an estimated $35.4K.
  • Emerald Advisers first reported a position in Anterix in Q2 2020 and held it in 9 quarters.
  • Emerald Advisers's Anterix position peaked at $66K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Anterix as of Q1 2023.

Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.